Status: Recruiting
Clinical Study of Adbelimumab in the Adjuvant Treatment of Esophageal Squamous Cell Carcinoma.
Evaluating the efficacy and safety of adebrelizumab for the adjuvant treatment of esophageal squamous cell cancer.
Participants needed: 142
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Hebei Medical University Fourth HospitalUpdated: Dec 5, 2025Locations: 1
Eligibility criteria
HB≥90g/L； [+5]
Patients initially diagnosed as unresectable (e.g. large metastatic lymph nodes)... [+9]